AIS Financial Facts
Product sales: 11.05MGross profit: 5.45M
See Full Income Statement
Deferred revenue: 5.8M
Deferred revenue - long term: 1.2M
See Full Balance Sheet
Antares Pharma Inc. (AIS) Earnings
|
Expand Research on AIS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +945.2% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/12/12 | Q411 | $0.00 | $0.00 | $0.00 | $5.4M | $4.88M | N/A |  | | Details | |
11/8/11  |
 |
Q311 | -$0.01 | -$0.01 | $0.00 | $3.9M | $3.85M | N/A | | | Details |
| 5/9/11 |
Q111 | -$0.02 | -$0.02 | $0.00 | $3.57M | $3.24M | N/A | | | Details | |
| 3/14/11 |
|
Q410 | -$0.02 | -$0.02 | $0.00 | $3.3M | $3.56M | N/A | | | Details |
